Literature DB >> 1410083

Eye-tracking dysfunction in the affective psychoses and schizophrenia.

W J Muir1, D M St Clair, D H Blackwood, H M Roxburgh, I Marshall.   

Abstract

Smooth pursuit eye movements to a sinusoidally moving target were recorded using the electro-oculogram in 49 subjects with bipolar disorder, 19 with major depressive disorder and 61 with definite schizophrenia, and compared with 145 normal controls. The signals were analysed in the frequency domain to yield a signal to noise ratio that is known to relate to accuracy of smooth pursuit. Smooth pursuit was found to be significantly poorer in schizophrenics than in bipolars, major depressed or controls. Eye-tracking performance was independent of the effects of neuroleptics, tricyclic antidepressants or lithium, and was not altered by the severity of depression in the affective psychoses. There was a small, but significant worsening of smooth pursuit with age in controls and schizophrenics, but this did not account for the group differences. The results support the view that among the major psychoses eye-tracking dysfunction is specific to schizophrenia.

Entities:  

Mesh:

Year:  1992        PMID: 1410083     DOI: 10.1017/s0033291700038034

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  4 in total

1.  Preclinical assessment of CNS drug action using eye movements in mice.

Authors:  Hugh Cahill; Amir Rattner; Jeremy Nathans
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

2.  Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.

Authors:  Rebekka Lencer; Andreas Sprenger; Margret S H Harris; James L Reilly; Matcheri S Keshavan; John A Sweeney
Journal:  Arch Gen Psychiatry       Date:  2008-10

Review 3.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

Review 4.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.